Foundry Partners’s Array Biopharma Inc ARRY Stock Holding History

Foundry Partners’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-55,986	Closed	-$2.59M	–	419
2019 Q2	$2.59M	Sell	55,986 -162	-0.3%	-$4.55K	0.1%	234
2019 Q1	$1.37M	Buy	+56,148	New	+$1.17M	0.05%	300

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Foundry Partners's ARRY Position: Q3 2019 in Review

Foundry Partners sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 55,986 shares — an estimated $2.59M sold.

Foundry Partners first reported a position in ARRY in Q1 2019 and held it in 2 quarters. The position peaked at $2.59M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

Foundry Partners reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
Foundry Partners sold 55,986 Array Biopharma Inc shares in Q3 2019, an estimated $2.59M.
Foundry Partners first reported a position in Array Biopharma Inc in Q1 2019 and held it in 2 quarters.
Foundry Partners's Array Biopharma Inc position peaked at $2.59M in Q2 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Foundry Partners's 13F filing for Q3 2019, filed 23 Oct 2019.